Community-Level Social, Environmental Factors Tied to Mild Cognitive Impairment
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Several community-wide social and environmental factors are associated with the onset of mild cognitive impairment (MCI) in older dementia-free individuals, according to a study published online Nov. 20 in the Journal of the American Geriatrics Society.
Mary Ganguli, M.D., M.P.H., from the University of Pittsburgh School of Medicine, and colleagues examined associations between community-wide social determinants of health and MCI. The analysis included data from 2,830 dementia-free individuals (aged 65 years and older).
The researchers found that unadjusted models revealed higher odds of MCI with higher Area Deprivation Index scores (odds ratio [OR], 1.01), higher fine particulate matter (PM2.5; OR, 1.16), higher homicide rates (OR, 1.007), lesser greenspace (OR, 0.99), and Southern state schooling (OR, 2.06). When adjusting for age, race, sex, and educational level, the Area Deprivation Index remained a significant risk factor. However, for PM2.5 and Southern state schooling, there were significant interactions with race; Black participants were more strongly affected than White participants.
"In this cohort, several community-wide social/environmental factors were associated with MCI," the authors write. "While clinicians should continue to encourage older adults to modify their individual risk factors, policy changes are needed to mitigate social determinants of health in the community."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-28 12:00
Read more
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
- Ordinal Score Predicts Freedom From Epilepsy One Year After Surgery
- Study Identifies Risk Factors Associated With Severe Stroke
- Nearly 260 Million Americans Could Be Overweight or Obese by 2050
- Risk for Mortality Up With Low Income in Type 2 Diabetes
- AI Might Help Pick Up Heart Trouble in Dogs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions